GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » Cyclically Adjusted FCF per Share

Lushang Freda Pharmaceutical Co (SHSE:600223) Cyclically Adjusted FCF per Share : ¥0.62 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Lushang Freda Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.004. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.62 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Lushang Freda Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 106.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Lushang Freda Pharmaceutical Co was 12.40% per year. The lowest was -49.40% per year. And the median was -12.60% per year.

As of today (2024-05-29), Lushang Freda Pharmaceutical Co's current stock price is ¥8.01. Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.62. Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 12.92.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Lushang Freda Pharmaceutical Co was 186.00. The lowest was 12.58. And the median was 37.27.


Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Lushang Freda Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.59 -0.98 0.08 0.18 0.34

Lushang Freda Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.28 0.35 0.34 0.62

Competitive Comparison of Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lushang Freda Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.004/115.2271*115.2271
=-0.004

Current CPI (Mar. 2024) = 115.2271.

Lushang Freda Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.039 98.200 -0.046
201409 -0.466 98.900 -0.543
201412 0.328 99.000 0.382
201503 -0.890 99.900 -1.027
201506 0.002 99.500 0.002
201509 -0.461 100.500 -0.529
201512 -0.556 100.600 -0.637
201603 -0.832 102.200 -0.938
201606 0.520 101.400 0.591
201609 -4.594 102.400 -5.169
201612 1.496 102.600 1.680
201703 0.590 103.200 0.659
201706 0.311 103.100 0.348
201709 0.560 104.100 0.620
201712 0.127 104.500 0.140
201803 -0.666 105.300 -0.729
201806 1.622 104.900 1.782
201809 0.194 106.600 0.210
201812 0.925 106.500 1.001
201903 0.394 107.700 0.422
201906 -4.116 107.700 -4.404
201909 -2.958 109.800 -3.104
201912 3.351 111.200 3.472
202003 -0.998 112.300 -1.024
202006 0.941 110.400 0.982
202009 1.544 111.700 1.593
202012 2.764 111.500 2.856
202103 0.211 112.662 0.216
202106 2.889 111.769 2.978
202109 1.310 112.215 1.345
202112 1.851 113.108 1.886
202203 -0.347 114.335 -0.350
202206 1.157 114.558 1.164
202209 0.269 115.339 0.269
202212 -0.193 115.116 -0.193
202303 0.047 115.116 0.047
202306 0.030 114.558 0.030
202309 0.073 115.339 0.073
202312 0.113 114.781 0.113
202403 -0.004 115.227 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Lushang Freda Pharmaceutical Co  (SHSE:600223) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Lushang Freda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=8.01/0.62
=12.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Lushang Freda Pharmaceutical Co was 186.00. The lowest was 12.58. And the median was 37.27.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Lushang Freda Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lushang Freda Pharmaceutical Co (SHSE:600223) Business Description

Traded in Other Exchanges
N/A
Address
No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
Executives
Li Hang senior management
Yin Wei Directors, senior managers
Shao Zhao Wei senior management
Wang Zhong Wu senior management
Dong Hong Lin Director
Zhou Hong Bo senior management
Li Lu senior management
Liu Zeng Wei senior management
Zhang Quan Li senior management
Xu Tao senior management
Ju Hai Bo Director
Zhao Xi Liang Director
Pi Xi Cai Supervisors

Lushang Freda Pharmaceutical Co (SHSE:600223) Headlines

No Headlines